| abstract |
An object of the present invention is to provide a combination therapy useful for treating cancer. A method of treating cancer in an individual comprising administering to the individual a combination therapy comprising an antagonist of programmed death 1 protein (PD-1) and a VEGFR inhibitor, wherein the PD-1 antagonist is , An anti-PD-1 monoclonal antibody comprising a heavy chain and a light chain, wherein the heavy and light chains each comprise a specific sequence, and wherein the VEGFR inhibitor is N-methyl-2- [3-((E ) -2-Pyridin-2-yl-vinyl) -1H-indazol-6-ylsulfanyl] -benzamide or a pharmaceutically acceptable salt thereof, for treating the cancer. [Selection diagram] None |